Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: The recent and ongoing coronavirus disease 2019 (COVID-19) pandemic has taken an unprecedented toll on adults critically ill with COVID-19 infection. While there is evidence that the burden of COVID-19 infection in hospitalized children is lesser than in their adult counterparts, to date, there are only limited reports describing COVID-19 in pediatric intensive care units (PICUs). OBJECTIVE: To provide an early description and characterization of COVID-19 infection in North American PICUs, focusing on mode of presentation, presence of comorbidities, severity of disease, therapeutic interventions, clinical trajectory, and early outcomes. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included children positive for COVID-19 admitted to 46 North American PICUs between March 14 and April 3, 2020. with follow-up to April 10, 2020. MAIN OUTCOMES AND MEASURES: Prehospital characteristics, clinical trajectory, and hospital outcomes of children admitted to PICUs with confirmed COVID-19 infection. RESULTS: Of the 48 children with COVID-19 admitted to participating PICUs, 25 (52%) were male, and the median (range) age was 13 (4.2-16.6) years. Forty patients (83%) had significant preexisting comorbidities; 35 (73%) presented with respiratory symptoms and 18 (38%) required invasive ventilation. Eleven patients (23%) had failure of 2 or more organ systems. Extracorporeal membrane oxygenation was required for 1 patient (2%). Targeted therapies were used in 28 patients (61%), with hydroxychloroquine being the most commonly used agent either alone (11 patients) or in combination (10 patients). At the completion of the follow-up period, 2 patients (4%) had died and 15 (31%) were still hospitalized, with 3 still requiring ventilatory support and 1 receiving extracorporeal membrane oxygenation. The median (range) PICU and hospital lengths of stay for those who had been discharged were 5 (3-9) days and 7 (4-13) days, respectively. CONCLUSIONS AND RELEVANCE: This early report describes the burden of COVID-19 infection in North American PICUs and confirms that severe illness in children is significant but far less frequent than in adults. Prehospital comorbidities appear to be an important factor in children. These preliminary observations provide an important platform for larger and more extensive studies of children with COVID-19 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
SARS-CoV-2 Infection in Children
Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,431
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek, S., Gierke, R., Hughes, M., McNamara, L. A., Pilishvili, T., & Skoff, T. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914e4 · Cited by 1,525
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
Costanzo, M., De Giglio, M. A. R., & Roviello, G. N. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200416131117 · Cited by 296
Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection
Giambenedetto, S. D., Ciccullo, A., Borghetti, A., Gambassi, G., Landi, F., Visconti, E., Verme, L. Z. D., Bernabei, R., Tamburrini, E., Cauda, R., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25897 · Cited by 156
Cited by
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Feldstein, L. R., Rose, E. B., Horwitz, S. M., Collins, J. P., Newhams, M. M., Son, M. B. F., Newburger, J. W., Kleinman, L. C., Heidemann, S. M., Martin, A. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021680 · Cited by 2,643
Self-citationMultisystem Inflammatory Syndrome in Children in New York State
Dufort, E. M., Koumans, E. H., Chow, E. J., Rosenthal, E. M., Muse, A., Rowlands, J., Barranco, M. A., Maxted, A. M., Rosenberg, E. S., Easton, D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021756 · Cited by 1,350
Ravens-Sieberer, U., Kaman, A., Erhart, M., Devine, J., Schlack, R., & Otto, C. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01726-5 · Cited by 1,029
COVID-19 in 7780 pediatric patients: A systematic review
Hoang, A., Chorath, K., Moreira, A., Evans, M., Burmeister-Morton, F., Burmeister, F., Naqvi, R., Petershack, M., & Moreira, A. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100433 · Cited by 533
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Ferris, A., Kernan, K. F., Schulert, G. S., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41454 · Cited by 531
Zimmermann, P., & Curtis, N. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320338 · Cited by 502
Davies, P., Evans, C., Kanthimathinathan, H. K., Lillie, J., Brierley, J., Waters, G., Johnson, M., Griffiths, B., du Pré, P., Mohammad, Z., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30215-7 · Cited by 475
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01949 · Cited by 475
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Ferris, A., Kernan, K. F., Schulert, G. S., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41616 · Cited by 412
Badulak, J., Antonini, M. V., Stead, C. M., Shekerdemian, L., Raman, L., Paden, M. L., Agerstrand, C., Bartlett, R. H., Barrett, N., Combes, A., et al. (2021) · ASAIO Journal · doi:10.1097/mat.0000000000001422 · Cited by 404
Self-citationUnderlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
Kompaniyets, L., Agathis, N. T., Nelson, J. M., Preston, L. E., Ko, J. Y., Belay, B., Pennington, A. F., Danielson, M. L., DeSisto, C. L., Chevinsky, J. R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11182 · Cited by 401
Lee, P. Y., Day-Lewis, M., Henderson, L. A., Friedman, K. G., Lo, J., Roberts, J. E., Lo, M. S., Platt, C. D., Chou, J., Hoyt, K. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141113 · Cited by 396
LaRovere, K. L., Riggs, B. J., Poussaint, T. Y., Young, C. C., Newhams, M. M., Maamari, M., Walker, T. C., Singh, A. R., Dapul, H., Hobbs, C. V., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0504 · Cited by 396
Self-citationSevere COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis
Tsankov, B. K., Allaire, J. M., Irvine, M. A., Lopez, A. A., Sauvé, L. J., Vallance, B. A., & Jacobson, K. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.163 · Cited by 370
Clinical manifestations of children with COVID‐19: A systematic review
de Souza, T. H., Nadal, J. A., Nogueira, R. J. N., Pereira, R. M., & Brandão, M. B. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24885 · Cited by 360
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Kernan, K. F., Schulert, G. S., Seo, P., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42062 · Cited by 296
Risk Factors for Severe COVID-19 in Children
Graff, K., Smith, C., Silveira, L., Jung, S., Curran-Hays, S., Jarjour, J., Carpenter, L., Pickard, K., Mattiucci, M., Fresia, J., et al. (2021) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003043 · Cited by 278
Risk Factors for Severe COVID-19 in Children
Woodruff, R. C., Campbell, A. P., Taylor, C. A., Chai, S. J., Kawasaki, B., Meek, J., Anderson, E. J., Weigel, A., Monroe, M. L., Reeg, L., et al. (2022) · Pediatrics · doi:10.1542/peds.2021-053418 · Cited by 268
Fontanet, A., Tondeur, L., Grant, R., Temmam, S., Madec, Y., Bigot, T., Grzelak, L., Cailleau, I., Besombes, C., Ungeheuer, M.-N., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.15.2001695 · Cited by 264
COVID-19 in Children: Where do we Stand?
Nikolopoulou, G. B., & Maltezou, H. C. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.07.002 · Cited by 262
Sacco, K., Castagnoli, R., Vakkilainen, S., Liu, C., Delmonte, O. M., Oguz, C., Kaplan, I. M., Alehashemi, S., Burbelo, P. D., Bhuyan, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01724-3 · Cited by 247
Christakis, D. A., Van Cleve, W., & Zimmerman, F. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.28786 · Cited by 161
COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
Feldman, E. L., Savelieff, M. G., Hayek, S. S., Pennathur, S., Kretzler, M., & Pop-Busui, R. (2020) · Diabetes · doi:10.2337/dbi20-0032 · Cited by 136
Risk Factors for Severity in Children with Coronavirus Disease 2019
Tsabouri, S., Makis, A., Kosmeri, C., & Siomou, E. (2021) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.07.014 · Cited by 132
“In a cross-sectional study of 48 children with COVID-19 admitted to US and Canadian intensive care units (ICUs), 52% were boys.(29) Severe disease has been reported in girls and the current data sug-”
Metadata
- Authors
- Shekerdemian, L. S., Mahmood, N. R., Wolfe, K. K., Riggs, B. J., Ross, C. E., McKiernan, C. A., Heidemann, S. M., Kleinman, L. C., Sen, A. I., Hall, M. W., Priestley, M. A., McGuire, J. K., Boukas, K., Sharron, M. P., Burns, J. P., & Collaborative, F. T. I. C.-1. P.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2020-09-01
- Volume
- 174
- Issue
- 9
- Pages
- 868
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W3022770671
- Cited by
- 985
- References
- 11
- FWCI
- 27.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.